Viewing Study NCT02633657


Ignite Creation Date: 2025-12-24 @ 7:03 PM
Ignite Modification Date: 2025-12-28 @ 7:12 PM
Study NCT ID: NCT02633657
Status: WITHDRAWN
Last Update Posted: 2021-04-12
First Post: 2015-12-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A PK and Safety Evaluation of HORIZANT (Gabapentin Enacarbil) in Adolescents With Moderate-to-Severe Primary RLS
Sponsor: XenoPort, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module